Springhill Fund Asset Management (Hk) CO LTD Cogent Biosciences, Inc. Transaction History
Springhill Fund Asset Management (Hk) CO LTD
- $61.6 Billion
- Q4 2024
A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 548,554 shares of COGT stock, worth $4.49 Million. This represents 6.95% of its overall portfolio holdings.
Number of Shares
548,554Holding current value
$4.49 Million% of portfolio
6.95%Shares
1 transactions
Others Institutions Holding COGT
# of Institutions
183Shares Held
112MCall Options Held
54.5KPut Options Held
422K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$74.5 Million4.5% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$59.6 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$57 Million8.87% of portfolio
-
Commodore Capital LP New York, NY6.88MShares$56.3 Million5.38% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA6.23MShares$50.9 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $538M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...